Abstract
Among the over 100 genes that encode for the various potassium channels known so far, the Kv10.1 exhibits properties that are quite unique. It is voltage-dependent and expressed almost exclusively in the nervous system. Surprisingly, it was found overexpressed in more than 70% of human cancer tissue of diverse origin, as well as in fast growing tissue such as placenta, germinal cells of testicles and in colon crypts. Its sub-cellular distribution allowed for elucidating its role in the cell cycle, during which it is regulated by growth factors and tumor suppressor genes such as the p53 and the RB1. In addition, Kv10.1 favors the internalization of the primary cilium, which is essential for cell division. Given that tumor cells grow and divide rapidly because they often have defective growth-factor signaling or defects in one of the mentioned genes, they frequently over-express Kv10.1, which can be detected using specific antibodies. Patients with high levels of Kv10.1 in their tumors have worse prognosis than those with low levels. In addition, blocking the function of Kv10.1 allows reducing cell proliferation. Therefore, Kv10.1 offers a novel diagnostic and therapeutic window in cancer treatment. © 2017. Acad. Colomb. Cienc. Ex. Fis. Nat.References
Agarwal, J.R., Griesinger, F., Stühmer, W., Pardo, L.A. 2010. The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia. Mol Cancer. 9: 18.
Arcangeli, A., Becchetti, A. 2015. Novel perspectives in cancer therapy: Targeting ion channels. Drug Resistance Updates. 21-22: 11-19.
Bai, Y., Liao, H., Liu, T., Zeng, X., Xiao, F., Luo, L. 2013. MiR- 296-3p regulates cell growth and multi-drug resistance of human glioblastoma by targeting ether-a-go-go (EAG1). Eur J Cancer. 49: 710-724.
Borowiec, A.S., Hague, F., Harir, N., Guenin, S., Guerineau, F., Gouilleux, F., Roudbaraki, M., Lassoued, K., Ouadid- Ahidouch, H. 2007. IGF-1 activates hEAG K+ channels through an Akt- ependent signaling pathway in breast cancer cells: role in cell proliferation. J Cell Physiol. 212:690-701.
Camacho, J., Sánchez, A., Stühmer, W., Pardo, L.A. 2000. Cytoskeletal interactions determine the electrophysiological properties of human EAG potassium channels. Pflugers Arch. 441: 167-174.
Díaz, L., Ceja-Ochoa, I., Restrepo-Angulo, I., Larrea, F., Ávila- Chávez, E., García-Becerra, R., Borja-Cacho, E., Barrera, D., Ahumada, E., Gariglio, P. et al. 2009. Estrogens and human papilloma virus oncogenes regulate human Ethera- go-go-1 potassium channel expression. Cancer Res. 69:3300-3307.
Downie, B.R., Sánchez, A., Knötgen, H., Contreras-Jurado, C., Gymnopoulos, M., Weber, C., Stühmer, W., Pardo, L.A. 2008. Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors. J Biol Chem. 283: 36234-36240.
García-Quiroz, J., Camacho, J. 2011. Astemizole: An old antihistamine as a new promising anti-cancer drug. Anti-Cancer Agents Med Chem. 11: 307-314.
Glickman, M.H., Ciechanover, A. 2002. The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction. Physiol Rev. 82: 373-428.
Hartung, F., Pardo, L.A. 2016. Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin. Eur Biophys J. 45: 709-719.
Hemmerlein, B., Weseloh, R.M., de Queiroz, F.M., Knötgen, H., Sánchez, A., Rubio, M.E., Martin, S., Schliephacke, T., Jenke, M., Radzun, H.J., et al. 2006. Overexpression of Eag1 potassium channels in clinical tumours. Mol Cancer. 5: 41.
Herrmann, S., Ninkovic, M., Kohl, T., Lörinczi, E., Pardo, L.A. 2012. Cortactin controls surface expression of the voltagegated potassium channel KV10.1. J Biol Chem. 287: 44151-44163.
Hwang, S.G., Lee, D.Y., Kim, J.Y., Seo, T.G., Choe, J.H. 2002. Human papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein- ndependent manner. J Biol Chem. 277: 2923-2930.
Kamb, A., Tsengcrank, J., Tanouye, M.A. 1988. Multiple products of the Drosophila shaker gene may contribute to potassium channel diversity. Neuron. 1: 421-430.
Kohl, T., Lörinczi, E., Pardo, L.A., Stühmer, W. 2011. Rapid internalization of the oncogenic K+ channel Kv10.1. PLoS ONE. 6: e26329.
Lastraioli, E., Perrone, G., Sette, A., Fiore, A., Crociani, O., Manoli, S., D’Amico, M., Masselli, M., Iorio, J., Callea, M., et al. 2015. hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma. Brit J Cancer. 112: 1076-1087.
Declaration of originality and transfer author's rights
The authors declare:
- The published data and reference materials have been duly identified with their respective credits and have been included in the bibliographic notes and citations that have been so identified and that should it be required, I have all releases and permissions from any copyrighted material.
- All material presented is free from any copyright and that I accept full legal responsibility for any legal claims relating to copyrighted intellectual property, fully exonerating from responsibility the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales.
- This work is unpublished and will not be sent to any other journal while waiting for the editorial decision of this journal. I declare that there is no conflict of interest in this manuscript.
- In case of publication of this article, all author´s rights are transferred to the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales, and so cannot be reproduced in any form without the express permission of it.
- By means of this document, if the article is accepted for publication by the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales, the Revista assumes the right to edit and publish the articles in national and international indices or data bases for academic and scientific use in paper, electronic, CD-ROM, internet form either of the complete text or any other known form known or to be known and non-commercial, respecting the rights of the authors.
Transfer of author rights
In case the article is approved for publication, the main author in representation of himself and his co-authors or the main author and his co-authors must cede the author rights of the corresponding article to the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales, except in the following cases:
The authors and co-authors will retain the right to revise, adapt, prepare derived works, oral presentations, and distribution to some colleagues of reprints of their own published work, if the corresponding credit is given to the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales. It is also permissible to publish the title of the work, summary, tables, and figures of the work in the corresponding web sites of the authors or their employers, also giving credit to the Revista.
If the work has been realized under contract, the author’s employer has the right to revise, adapt, prepare derivative works, reproduce, or distribute in hard copy the published work, in a secure manner and for the exclusive use of his employees.
If the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales were approached for permission by a third party for using, printing, or publishing specifically articles already published, the Revista must obtain the express permission of the author and co-authors of the work or of the employer except for use in classrooms, libraries, or reprinted in a collective work. The Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales reserves the possible use in its front cover of figures submitted with the manuscripts.
No other right, other than the author’s right, can be claimed by the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales.